论文部分内容阅读
目的研讨哮喘病人运用布地奈德粉吸入剂治疗的临床作用。方法回顾性分析2013年1月-2016年1月我院接治的200例哮喘病人资料,并根据不同给药方案分成两组,Ⅰ组98例接受常规对症治疗,Ⅱ组102例接受布地奈德粉吸入剂治疗,对该两种给药方案的临床应用情况做评估。结果Ⅱ组病人接受治疗后的日间、夜间症状评测结果与Ⅰ组相比均显著下降,统计学成立(P<0.05)。治疗前,两组的FVC、FEV1等指标水平相差不大,统计学不成立(P>0.05);治疗后,Ⅱ组上述肺功能指标值均显著改善,优于Ⅰ组,统计学成立(P<0.05)。两组接受相应方案治疗后,Ⅱ组总有效率达到93.1%(95/102),与Ⅰ组的总有效率77.6%(76/98)相比显著提高,统计学成立(P<0.05)。结论在常规对症处理哮喘病的同时,给予布地奈德粉吸入剂用药,能够有效缓解哮喘症状、改善病人的肺功能,值得推荐。
Objective To study the clinical effect of budesonide inhalation in patients with asthma. Methods The data of 200 cases of asthma treated in our hospital from January 2013 to January 2016 were retrospectively analyzed and divided into two groups according to different dosage regimens. Group Ⅰ received 98 cases of conventional symptomatic treatment and group Ⅱ received 102 cases of budesonide. German powder inhaler treatment, evaluation of the clinical application of the two dosing regimens. Results The results of daytime and nighttime symptom evaluation in group Ⅱ were significantly lower than those in group Ⅰ (P <0.05). Before treatment, the levels of FVC and FEV1 in the two groups were not significantly different (P> 0.05). After treatment, the indexes of pulmonary function in group Ⅱ were significantly improved, which were better than those in group Ⅰ (P < 0.05). The total effective rate of group Ⅱ was 93.1% (95/102) after treatment with the corresponding regimen, which was significantly higher than that of group Ⅰ (77.6%, 76/98). The statistic was established (P <0.05). Conclusions In the routine symptomatic treatment of asthma, administration of budesonide powder inhaler, which can effectively relieve the symptoms of asthma and improve the lung function of patients, is worth recommending.